Management raised guidance and admitted they might lose share to their main competitor in the same call.
Thesis: Advantest is capitalizing on scarcity, not dominance. They are a 'Capacity Ceiling' story—earning record profits because they cannot build enough machines to satisfy demand. This pricing power is real but temporary. The structural risk is the admitted share loss at the leading edge (3nm/2nm transitions) next year. They are reallocating legacy parts to high-end orders to hide consumer weakness, but you cannot reallocate your way out of a technical deficit.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Calendar year 2023 node transition at the 'largest customer for your competitor' (likely Apple/TSMC) which management flagged as a share loss risk.
Key Risk: Supply chain rigidity. Lead times remain 9-12 months. If demand rolls over, they have no flexibility to pivot because they are legally committed to parts they couldn't ship earlier.
The Tell: Yoshida's direct admission on share loss: 'If their peers increase their presence, that may mean that our share would drop.' Most CEOs would deflect with 'we remain competitive.' He admitted the bear case live.
Friction Level: HIGH_FRICTION — Bulls see a 'Beat and Raise Machine' protected by backlog. Bears see a 'Capacity Ceiling' and explicit admission of future share loss at the leading edge.
Report not found
The report data is no longer available. Please return to the archive.